Literature DB >> 23413156

Dysautonomia is frequent in Machado-Joseph disease: clinical and neurophysiological evaluation.

Karen A G Takazaki1, Anelyssa D'Abreu, Anamarli Nucci, Iscia Lopes-Cendes, Marcondes C França.   

Abstract

Autonomic dysfunction has been already described in patients with SCA3/MJD, but several important questions remain unanswered. The objectives of this study are to determine the frequency and the intensity of autonomic manifestations in SCA3/MJD, as well as to identify possible correlations between autonomic manifestations and genetic and clinical parameters. We have performed clinical and electrophysiological evaluations of 40 patients with SCA3/MJD and 38 healthy controls. We used the Scale for the Assessment and Rating of Ataxia (SARA) and the scales for Outcomes in Parkinson's Disease: Autonomic Questionnaire to quantify the severity of ataxia and autonomic complaints, respectively. We also studied heart rate variability at rest, during orthostatic challenge (30:15 ratio), Valsalva maneuver (Valsalva index), and deep breathing (E/I ratio). We evaluated spectral analyses of RR intervals at rest and the sympathetic skin response. Mean RR intervals at rest and the 30:15 ratio were different between patients and controls (811.8 versus 933.4 ms; p = 0.001 and 1.10 versus 1.15; p = 0.038, respectively). The Valsalva index and the E/I ratio were similar between the groups (p = 0.373 and p = 0.08). Spectral analysis presented distinct results in patients and controls, related to low- and high-frequency power (p < 0.001 and <0.001, respectively). We found cardiovascular and sympathetic sweat disautonomia in 30 % and 45 % of the patients with SCA3/MJD. Autonomic manifestations were related neither to genetic (CAG repeat length) nor clinical parameters (age, disease duration, SARA scores). Autonomic dysfunction is frequent and sometimes disabling in SCA3/MJD. We found evidence of both cardiovascular and sudomotor dysfunction in the disease.

Entities:  

Mesh:

Year:  2013        PMID: 23413156     DOI: 10.1007/s12311-013-0458-y

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  32 in total

1.  Machado-Joseph disease: cerebellar ataxia and autonomic dysfunction in a patient with the shortest known expanded allele (56 CAG repeat units) of the MJD1 gene.

Authors:  Y Takiyama; K Sakoe; I Nakano; M Nishizawa
Journal:  Neurology       Date:  1997-08       Impact factor: 9.910

Review 2.  Sympathetic skin response: a decade later.

Authors:  G R Arunodaya; A B Taly
Journal:  J Neurol Sci       Date:  1995-04       Impact factor: 3.181

3.  Peripheral neuropathy of Machado-Joseph disease in Taiwan: a morphometric and genetic study.

Authors:  Kon-Ping Lin; Bing-Wen Soong
Journal:  Eur Neurol       Date:  2002       Impact factor: 1.710

4.  Autonomic dysfunction in Machado-Joseph disease.

Authors:  Tu-Hsueh Yeh; Chin-Song Lu; Yah-Huei Wu Chou; Chok-Chean Chong; Tony Wu; Nai-Hui Han; Rou-Shayn Chen
Journal:  Arch Neurol       Date:  2005-04

5.  Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease.

Authors:  N A Aziz; G V Anguelova; J Marinus; J G van Dijk; R A C Roos
Journal:  Eur J Neurol       Date:  2010-02-24       Impact factor: 6.089

6.  A comparative study of cardiac dysautonomia in autosomal dominant spinocerebellar ataxias and idiopathic sporadic ataxias.

Authors:  M Netravathi; T N Sathyaprabha; K Jayalaxmi; P Datta; M Nirmala; P K Pal
Journal:  Acta Neurol Scand       Date:  2009-09       Impact factor: 3.209

7.  Psychometric properties of the SCOPA-AUT Brazilian Portuguese version.

Authors:  Francisco Javier Carod-Artal; Luciola da Silveira Ribeiro; Wladimir Kummer; Pablo Martinez-Martin
Journal:  Mov Disord       Date:  2010-01-30       Impact factor: 10.338

8.  Chronic pain in Machado-Joseph disease: a frequent and disabling symptom.

Authors:  Marcondes C França; Anelyssa D'Abreu; Joseph H Friedman; Anamarli Nucci; Iscia Lopes-Cendes
Journal:  Arch Neurol       Date:  2007-12

Review 9.  Caring for Machado-Joseph disease: current understanding and how to help patients.

Authors:  Anelyssa D'Abreu; Marcondes C França; Henry L Paulson; Iscia Lopes-Cendes
Journal:  Parkinsonism Relat Disord       Date:  2009-10-06       Impact factor: 4.891

10.  Cognitive and olfactory deficits in Machado-Joseph disease: a dopamine transporter study.

Authors:  Pedro Braga-Neto; Andre C Felicio; Marcelo Q Hoexter; José Luiz Pedroso; Lívia Almeida Dutra; Helena Alessi; Thaís Minett; Ruth F Santos-Galduroz; Antônio José da Rocha; Lucas A L Garcia; Paulo Henrique F Bertolucci; Rodrigo A Bressan; Orlando Graziani Povoas Barsottini
Journal:  Parkinsonism Relat Disord       Date:  2012-05-08       Impact factor: 4.891

View more
  4 in total

1.  Increased catabolic state in spinocerebellar ataxia type 1 patients.

Authors:  Anja Mähler; Jochen Steiniger; Matthias Endres; Friedemann Paul; Michael Boschmann; Sarah Doss
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

2.  Establish a Nomogram to Predict Falls in Spinocerebellar Ataxia Type 3.

Authors:  Junyu Lin; Lingyu Zhang; Bei Cao; Qianqian Wei; Ruwei Ou; Yanbing Hou; Xinran Xu; Kuncheng Liu; Xiaojing Gu; Huifang Shang
Journal:  Front Neurol       Date:  2021-01-27       Impact factor: 4.003

3.  Autonomic dysfunction as the initial presentation in spinocerebellar ataxia type 3: A case report and review of the literature.

Authors:  Yi Jin; Yuchao Chen; Dan Li; Mengqiu Qiu; Menglu Zhou; Zhouyao Hu; Qiusi Cai; Xulin Weng; Xiaodong Lu; Bin Wu
Journal:  Front Neurol       Date:  2022-09-27       Impact factor: 4.086

Review 4.  The Intersection Between Cerebellar Ataxia and Neuropathy: a Proposed Classification and a Diagnostic Approach.

Authors:  Cristina Saade Jaques; Marcio Luiz Escorcio-Bezerra; José Luiz Pedroso; Orlando Graziani Povoas Barsottini
Journal:  Cerebellum       Date:  2021-08-09       Impact factor: 3.847

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.